Remote ischaemic preconditioning influences the levels of acylcarnitines in vascular surgery: a randomised clinical trial

• Published in: Nutrition & metabolism Vol. 17; no. 1; p. 76
• Main Authors: Kasepalu, Teele, Kuusik, Karl, Lepner, Urmas, Starkopf, Joel, Zilmer, Mihkel, Eha, Jaan, Vähi, Mare, Kals, Jaak
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.09.2020; BioMed Central; BMC
• Subjects: Acylcarnitines; Anesthesia; Aneurysm; Biomarkers; Blood pressure; Carnitine; Clinical trials; Fatty acids; Ischaemic preconditioning; Ischemia; Laboratories; Medical research; Metabolism; Metabolites; Mitochondria; Normal distribution; Patients; Population studies; Reperfusion; Statistical analysis; Surgery; Vascular surgery; United States > US; Ischaemic preconditioning; Mitochondria; Vascular surgery; Acylcarnitines
• ISSN: 1743-7075; 1743-7075
• DOI: 10.1186/s12986-020-00495-3

Vascular surgery patients have reduced tissues` blood supply, which may lead to mitochondrial dysfunction and accumulation of acylcarnitines (ACs). It has been suggested that remote ischaemic preconditioning (RIPC) has its organ protective effect via promoting mitochondrial function. The aim of this study was to evaluate the effect of RIPC on the profile of ACs in the vascular surgery patients. This is a randomised, sham-controlled, double-blinded, single-centre study. Patients undergoing open surgical repair of abdominal aortic aneurysm, surgical lower limb revascularisation surgery or carotid endarterectomy were recruited non-consecutively. The RIPC protocol consisting of 4 cycles of 5 min of ischaemia, followed by 5 min of reperfusion, was applied. A blood pressure cuff was used for RIPC or a sham procedure. Blood was collected preoperatively and approximately 24 h postoperatively. The profile of ACs was analysed using the AbsoluteIDQp180 kit (Biocrates Life Sciences AG, Innsbruck, Austria). Ninety-eight patients were recruited and randomised into the study groups and 45 patients from the RIPC group and 47 patients from the sham group were included in final analysis. There was a statistically significant difference between the groups regarding the changes in C3-OH (  = 0.023)-there was a decrease (- 0.007 µmol/L, ± 0.020 µmol/L,  = 0.0233) in the RIPC group and increase (0.002 µmol/L, ± 0.015 µmol/L,  = 0.481) in the sham group. Additionally, a decrease from baseline to 24 h after surgery (  < 0.05) was detected both in the sham and the RIPC group in the levels of following ACs: C2, C8, C10, C10:1, C12, C12:1, C14:1, C14:2, C16, C16:1, C18, C18:1, C18:2. In the sham group, there was an increase (  < 0.05) in the levels of C0 (carnitine) and a decrease in the level of C18:1-OH. In the RIPC group, a decrease (  < 0.05) was noted in the levels of C3-OH, C3-DC (C4-OH), C6:1, C9, C10:2. It can be concluded that RIPC may have an effect on the levels of ACs and might therefore have protective effects on mitochondria in the vascular surgery patients. Further larger studies conducted on homogenous populations are needed to make more definite conclusions about the effect of RIPC on the metabolism of ACs. ClinicalTrials.gov database, NCT02689414. Registered 24 February 2016-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02689414.